Caplin Point Laboratories Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Caplin Point Laboratories Limited Company Profile :

Caplin Point Laboratories Limited is an India-based company engaged in the business of pharmaceuticals formulations.

The Company offers a range of products, which include analgesics, antipyretics, antacids, anti-amoebic, anti-bacterial, antibiotic, anti-cold, antihistaminic, anti-diabetic, anti-malarial, oral rehydration salts, urinary antibacterial, vitamin supplements, novel and special products, biotech and other lyophilized products, effervescent tablets, softgel capsules, and medical and hospital consumables, among others.

The Company has three facilities for manufacturing a range of dosage forms and products for various segments of the pharmaceutical industry.


Caplin Point Laboratories ResultsBSE Code : 524742
NSE Symbol : CAPLIPOINT
ISIN No. : INE475E01018
Industry : Pharmaceuticals
Face Value : Rs. 10.00


If you are an investor who has shares of Caplin Point Laboratories or you are an stock market analyst then i am sure you might for Quarterly Results of Caplin Point Laboratories.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Caplin Point Laboratories. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Caplin Point Laboratories.

Caplin Point Laboratories Q1 Results 2016-17 :

Caplin Point Laboratories will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Caplin Point Laboratories will announce its Q2 FY 2016-17 Results in the month of October 2017.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Caplin Point Laboratories will announce its Q3 FY 2016-17 Results in the month of January 2017.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Caplin Point Laboratories will announce its Q4 FY 2016-17 Results in the month of April 2017.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Caplin Point Laboratories will announce its FY 2016-17 Results in the month of April 2017.

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Caplin Point Laboratories Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 231.29 238.72
Other Income 3.47  3.66
Total Income  234.77  242.38
Expenditure  -168.98  -182.21
Interest  -0.11  -0.11
Depreciation  -7.30  -7.47
PBT  58.38 60.05
Tax  -13.05  -14.28
Net Profit  45.33  45.76
Equity  15.11  15.11
EPS  29.99  30.29

Note : If you like this information about Caplin Point Laboratories Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.